These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 21925104)

  • 21. Association of Human Immunoglobulin G1 Heavy Chain Variants With Neutralization Capacity and Antibody-Dependent Cellular Cytotoxicity Against Human Cytomegalovirus.
    Vietzen H; Görzer I; Puchhammer-Stöckl E
    J Infect Dis; 2016 Oct; 214(8):1175-9. PubMed ID: 27465644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glycoprotein B of human cytomegalovirus promotes virion penetration into cells, transmission of infection from cell to cell, and fusion of infected cells.
    Navarro D; Paz P; Tugizov S; Topp K; La Vail J; Pereira L
    Virology; 1993 Nov; 197(1):143-58. PubMed ID: 7692667
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A high-affinity native human antibody neutralizes human cytomegalovirus infection of diverse cell types.
    Kauvar LM; Liu K; Park M; DeChene N; Stephenson R; Tenorio E; Ellsworth SL; Tabata T; Petitt M; Tsuge M; Fang-Hoover J; Adler SP; Cui X; McVoy MA; Pereira L
    Antimicrob Agents Chemother; 2015 Mar; 59(3):1558-68. PubMed ID: 25534746
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neutralization of rhesus cytomegalovirus IL-10 reduces horizontal transmission and alters long-term immunity.
    Deere JD; Chang WLW; Villalobos A; Schmidt KA; Deshpande A; Castillo LD; Fike J; Walter MR; Barry PA; Hartigan-O'Connor DJ
    Proc Natl Acad Sci U S A; 2019 Jun; 116(26):13036-13041. PubMed ID: 31189602
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathogen at the Gates: Human Cytomegalovirus Entry and Cell Tropism.
    Nguyen CC; Kamil JP
    Viruses; 2018 Dec; 10(12):. PubMed ID: 30544948
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phosphorylation of Golgi Peripheral Membrane Protein Grasp65 Is an Integral Step in the Formation of the Human Cytomegalovirus Cytoplasmic Assembly Compartment.
    Rebmann GM; Grabski R; Sanchez V; Britt WJ
    mBio; 2016 Oct; 7(5):. PubMed ID: 27703074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The human cytomegalovirus (HCMV) tegument protein UL94 is essential for secondary envelopment of HCMV virions.
    Phillips SL; Bresnahan WA
    J Virol; 2012 Mar; 86(5):2523-32. PubMed ID: 22171267
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A two-step screening approach for the identification of blood donors with highly and broadly neutralizing capacities against human cytomegalovirus.
    Falk JJ; Winkelmann M; Schrezenmeier H; Stöhr D; Sinzger C; Lotfi R
    Transfusion; 2017 Feb; 57(2):412-422. PubMed ID: 27861998
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of Elite Neutralizers With Broad and Potent Neutralizing Activity Against Human Cytomegalovirus (HCMV) in a Population of HCMV-Seropositive Blood Donors.
    Falk JJ; Winkelmann M; Stöhr D; Alt M; Schrezenmeier H; Krawczyk A; Lotfi R; Sinzger C
    J Infect Dis; 2018 Aug; 218(6):876-885. PubMed ID: 29684155
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human cytomegalovirus vaccine based on the envelope gH/gL pentamer complex.
    Wussow F; Chiuppesi F; Martinez J; Campo J; Johnson E; Flechsig C; Newell M; Tran E; Ortiz J; La Rosa C; Herrmann A; Longmate J; Chakraborty R; Barry PA; Diamond DJ
    PLoS Pathog; 2014 Nov; 10(11):e1004524. PubMed ID: 25412505
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Function of human cytomegalovirus glycoprotein B: syncytium formation in cells constitutively expressing gB is blocked by virus-neutralizing antibodies.
    Tugizov S; Navarro D; Paz P; Wang Y; Qadri I; Pereira L
    Virology; 1994 Jun; 201(2):263-76. PubMed ID: 8184537
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isolation of human monoclonal antibodies that potently neutralize human cytomegalovirus infection by targeting different epitopes on the gH/gL/UL128-131A complex.
    Macagno A; Bernasconi NL; Vanzetta F; Dander E; Sarasini A; Revello MG; Gerna G; Sallusto F; Lanzavecchia A
    J Virol; 2010 Jan; 84(2):1005-13. PubMed ID: 19889756
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human cytomegalovirus serum neutralizing antibodies block virus infection of endothelial/epithelial cells, but not fibroblasts, early during primary infection.
    Gerna G; Sarasini A; Patrone M; Percivalle E; Fiorina L; Campanini G; Gallina A; Baldanti F; Revello MG
    J Gen Virol; 2008 Apr; 89(Pt 4):853-865. PubMed ID: 18343825
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human Cytomegalovirus Particles Treated with Specific Antibodies Induce Intrinsic and Adaptive but Not Innate Immune Responses.
    Wu Z; Qin R; Wang L; Bosso M; Scherer M; Stamminger T; Hotter D; Mertens T; Frascaroli G
    J Virol; 2017 Nov; 91(22):. PubMed ID: 28878085
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human cytomegalovirus tropism for endothelial/epithelial cells: scientific background and clinical implications.
    Revello MG; Gerna G
    Rev Med Virol; 2010 May; 20(3):136-55. PubMed ID: 20084641
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative Electron Microscopy to Study HCMV Morphogenesis.
    Read C; Walther P; von Einem J
    Methods Mol Biol; 2021; 2244():265-289. PubMed ID: 33555592
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Replication-Defective Human Cytomegalovirus Vaccine Elicits Humoral Immune Responses Analogous to Those with Natural Infection.
    Liu Y; Freed DC; Li L; Tang A; Li F; Murray EM; Adler SP; McVoy MA; Rupp RE; Barrett D; Ye X; Zhang N; Beck K; Culp T; Das R; Song L; Vora K; Zhu H; Wang D; Espeseth AS; An Z; Musey L; Fu TM
    J Virol; 2019 Dec; 93(23):. PubMed ID: 31511385
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monoclonal antibodies targeting nonstructural viral antigens can activate ADCC against human cytomegalovirus.
    Vlahava VM; Murrell I; Zhuang L; Aicheler RJ; Lim E; Miners KL; Ladell K; Suárez NM; Price DA; Davison AJ; Wilkinson GW; Wills MR; Weekes MP; Wang EC; Stanton RJ
    J Clin Invest; 2021 Feb; 131(4):. PubMed ID: 33586678
    [TBL] [Abstract][Full Text] [Related]  

  • 39. B cell repertoire analysis identifies new antigenic domains on glycoprotein B of human cytomegalovirus which are target of neutralizing antibodies.
    Pötzsch S; Spindler N; Wiegers AK; Fisch T; Rücker P; Sticht H; Grieb N; Baroti T; Weisel F; Stamminger T; Martin-Parras L; Mach M; Winkler TH
    PLoS Pathog; 2011 Aug; 7(8):e1002172. PubMed ID: 21852946
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neutralizing and ELISA IgG antibodies to human cytomegalovirus glycoprotein complexes may help date the onset of primary infection in pregnancy.
    Lilleri D; Gerna G; Furione M; Zavattoni M; Spinillo A
    J Clin Virol; 2016 Aug; 81():16-24. PubMed ID: 27289427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.